International guidelines advise people with diabetes to wear close-toed, thick-soled footwear to protect against foot ulceration. However, this type of footwear is incompatible with some of the cultures, climates, and socioeconomic conditions in many low- and middle-income countries (LMICs). This scoping review aims to summarize what is known about footwear used by people with diabetes in LMICs and consider whether international diabetic foot guidelines are practical and actionable in these contexts, given current practices. PubMed, CINAHL, Scopus, Embase, Web of Science, Latin American and Caribbean Health Sciences Literature, and African Journals Online were searched for articles that documented the footwear used by people with diabetes in LMICs. Twenty-five studies from 13 countries were eligible for inclusion and indicated that a large proportion of people with diabetes wear footwear that is considered inappropriate by current guidance, with sandals and flip-flops being popular choices in a majority of the studies. Reasons given for these choices include poverty, lack of awareness of and provider communication about the importance of footwear selection, comfort, and cultural norms. We recommend that LMIC health care systems relying on international guidelines critically consider whether their recommendations are sensible in their settings. Diabetic foot experts and LMIC-based health care stakeholders should collaborate to design alternative guidelines, strategies, and interventions specifically for LMIC contexts to increase preventative practice feasibility and uptake.
Interest in applying a “lean” philosophy to design has been slowly growing in recent years, but there are still few broadly applicable methodologies and illustrative cases published in the literature to guide lean design processes. Lean approaches promise cost reduction and increased product value, which could be particularly beneficial in product development for low- and middle-income country markets, where value demands are high. We use the clinical need of efficient diabetic foot risk assessment in lowresource healthcare settings to present an example of lean early-stage design of a medical device. The background of existing medical literature and commercial products is intentionally leveraged throughout the design process to streamline development and minimize the need for independent validation of product strategies and design features. Our approach resulted in an efficient design process that generated a novel, purely mechanical plantar pressure evaluation device that can indicate high risk of diabetic foot ulcer in resource-constrained settings. This case provides a practical example of how design processes can be adapted to be leaner where there are large gains from minimizing design cycle time and cost.
The objective of this work is to identify the most effective techniques for reweighting anthropometric data such that it accurately represents a target user population. Seven methods are compared, including uniform weighting, stratification and permutations of nearest neighbour (NN) reweighting. The analysis illuminates the performance of existing and novel approaches to reweighting data specifically for approximating body size and shape (‘anthropometry’). While uniform weighting and stratified sampling are often used in this field, the present analysis indicates that lower-order NN approaches will produce more representative results. Although anthropometric data are crucial to the design of artefacts, tasks and environments, finding appropriate representative data is challenging. Designers and ergonomists are unlikely to find data that are simultaneously accessible, up-to-date, detailed and from the relevant population. The application of new statistical weights – reweighting – is one useful strategy for meeting this shortfall. This research indicates the best methods for reweighting and provides guidance for sampling strategies in future data collection efforts. Practitioner Summary: Reweighting anthropometric data is one strategy for matching available data to a target user population. Stratified sampling is often used as the method for calculating weights, but it has been shown to produce inaccurate estimates. This research examines seven strategies and finds low-order NN approaches are the more accurate methods.
Diabetic foot complications constitute a large and rapidly growing global health problem, causing one million lower-extremity amputations annually. These amputations are typically preceded by preventable diabetic foot ulcers (DFUs). However, 80% of the world’s diabetics now reside in low- and middle-income countries, where many healthcare settings lack the resources required to implement recommended DFU risk assessment and prevention strategies. There is an unmet need for a more resource-efficient DFU risk assessment method. In this study, a low-cost, purely mechanical plantar pressure evaluation device was designed toward this end. The device consists of a grid of plastic bistable compliant mechanisms, which present a visual series of binary outputs in response to applied pressure. By having diabetic patients step on the device, non-specialist healthcare providers can easily assess patients’ plantar pressures, which are predictive of future DFUs. A prototype was fabricated and pilot-tested with 41 healthy subjects. It demonstrated a sensitivity of 25.6%, although sensitivity reached 60% for heavier subjects. Sensitivity could likely be significantly improved by lowering the device’s profile and increasing the sensing area. Strained health systems may then be able to use this device to allocate scarce healthcare resources more efficiently to prevent costly DFUs and amputations.
Blood clots originating in the left atrial appendage (LAA) are the leading cause of ischemic stroke in patients with nonvalvular atrial fibrillation (AF). Complications from and contraindications to oral anticoagulants (OACs), in addition to the recent successes of endocardial LAA closure devices, have driven increased interest in mechanical LAA occlusion. However, current devices are limited in their abilities to accommodate diverse LAA anatomies, motivating the development of a novel endocardial LAA occluder that supports more anatomical variability. We present the design of an in-situ expandable plug as well as an accompanying pacifier module for LAA occlusion. The final design accommodates LAA diameter ranges of 14 millimeters for each device size (10-24mm and 24-38mm), double that of any approved device. This adaptability can help to overcome imperfect pre-procedural imaging and suboptimal device fit. Benchtop tug and leak tests demonstrate the stability and sealing capacities of the design.